[
    [
        {
            "time": "",
            "original_text": "贝达药业2019年度净利润2.31亿元 “埃克替尼”累计销售破70亿元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2019年度",
                    "净利润",
                    "2.31亿元",
                    "埃克替尼",
                    "累计销售",
                    "70亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业2019年度净利润2.31亿元 “埃克替尼”累计销售破70亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "拟10股派1.9元，贝达药业去年净利涨38.37%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "10股派1.9元",
                    "净利",
                    "38.37%"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "拟10股派1.9元，贝达药业去年净利涨38.37%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "贝达药业(300558.SZ)：2019年度净利润升38.37%至2.31亿元 拟10派1.9元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "300558.SZ",
                    "2019年度",
                    "净利润",
                    "38.37%",
                    "2.31亿元",
                    "10派1.9元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)：2019年度净利润升38.37%至2.31亿元 拟10派1.9元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【天风医药】贝达药业：年报业绩符合预期，公司开始步入收获期",
            "features": {
                "keywords": [
                    "天风医药",
                    "贝达药业",
                    "年报",
                    "业绩",
                    "符合预期",
                    "收获期"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】贝达药业：年报业绩符合预期，公司开始步入收获期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]